Celltrion to Conduct Trial of Remsima as COVID-19 Therapeutics in UK
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
Tag: therapeutics
Bioneer’s Molecular Diagnostic Equipment Attracts Global Attention
Bioneer Co., a South Korean biotech firm, on Wednesday, said that it signed a memorandum of understanding (MOU) to source ...
Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...